Virus News and Research

Latest Virus News and Research

Adapting biological research and development to COVID-19

In this interview, News-Medical talks to Dr Yuning Chen, about the work he does with Sino Biological and how they have adapted their research & development to the COVID-19 pandemic.

From Sino Biological Inc. 8 Oct 2021

Scientists study immune response to COVID-19 in patients with different levels of disease severity

Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.

8 Oct 2021

Chilblain-like lesions and COVID-19

The ongoing COVID-19 pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been responsible for various cutaneous manifestations. Among them, chilblain-like lesions (CLL) have been found to occur more frequently.

7 Oct 2021

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection.

7 Oct 2021

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

A team of researchers has explored the possibility of coating surfaces with TiO2 as a tool to inactivate SARS-CoV-2.

7 Oct 2021

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

In this review, researchers summarized the therapeutic and pathogenic role of IL-7 in patients with COVID-19 and examined the promising role of IL-7 as a vaccine adjuvant.

7 Oct 2021

Scientists develop a cell-free assay to screen SARS-CoV-2 entry inhibitors

Scientists have developed and validated a cell-free fluorescence assay for the rapid screening of protein inhibitors.

7 Oct 2021

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.

7 Oct 2021

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

A new study published on the medRxiv* preprint server focused on a patient with a persistent symptomatic viral infection for over a year. Researchers amplified sub-genomic transcripts for the E gene (sgE) using nasopharyngeal samples of the patient infected with SARS-CoV-2 over the course of 335 days.

6 Oct 2021

New model can predict the risk of airborne COVID-19 infection in offices and schools

As more UK workers and students return to offices and schools, a new model has been developed to predict the risk of airborne COVID-19 infection in such environments.

6 Oct 2021

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

A new study, published on the medRxiv* preprint server, suggested that selective pressures induced by the administration of monoclonal antibodies (Bamlanivimab) may require increased genomic surveillance to identify and control the spread of therapy-induced variants.

6 Oct 2021

Novel proteomics approach predicts severe COVID-19 outcomes

Researchers in the United States, Canada, and the UK have developed a potential new approach to predicting severe and critical outcomes among patients with coronavirus disease 2019 (COVID-19).

6 Oct 2021

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

A new study posted to the medRxiv* server and led by Dr. Mattia D'Agostino, Dr. Eleonora Pavoni and Dr. Alice Romagnoli from the Polytechnic University of Marche in Ancona (Italy), a gFET biosensor that uses angiotensin-converting enzyme 2 (ACE2) as a bioreceptor has been put forth as a viable solution.

6 Oct 2021

COVID-19 vaccine clinical trial for children is underway in St. Louis

A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or placebo at St. Louis Children's Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.

6 Oct 2021

Virus News and Research

Latest Virus News and Research

Adapting biological research and development to COVID-19

Scientists study immune response to COVID-19 in patients with different levels of disease severity

Chilblain-like lesions and COVID-19

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Scientists develop a cell-free assay to screen SARS-CoV-2 entry inhibitors

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

New model can predict the risk of airborne COVID-19 infection in offices and schools

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

Novel proteomics approach predicts severe COVID-19 outcomes

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

COVID-19 vaccine clinical trial for children is underway in St. Louis

Does vaccination prevent long COVID?

Moderna COVID vaccine booster dose results in immune memory

Research on twins indicates strong genetic influences in COVID-19

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Durability of immunity to SARS-CoV-2 reinfection

California vaccine mandate extends to aides for people with disabilities

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in